NCT05406479View on ClinicalTrials.gov

Bedaquiline Enhanced Post ExpOsure Prophylaxis for Leprosy (Phase 2)

PHASE2CompletedINTERVENTIONAL
Enrollment

313

Participants

Timeline

Start Date

July 14, 2022

Primary Completion Date

January 26, 2023

Study Completion Date

January 26, 2023

Conditions
Leprosy
Interventions
DRUG

BE-PEP (Bedaquiline)

Single dose of Bedaquiline

DRUG

SDR-PEP

Single dose of Rifampicin

DRUG

BE-PEP (Rifampicine)

Single dose of Rifampicin

Trial Locations (1)

Unknown

Fondation Damien, Gege

All Listed Sponsors
collaborator

Damien Foundation

OTHER

lead

Institute of Tropical Medicine, Belgium

OTHER